Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

280.06 -1.16 (-0.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
53 54 Next >
This Is What Whales Are Betting On Amgen
Via Benzinga
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive. 
Via InvestorPlace
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
Investors interested in a steadily rising stream of passive income will find what they're looking for with these dividend payers. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
It faces both clinical and competitive barriers, but they might not matter. 
Via The Motley Fool
Drivers And Stock Pickers
As opposed to drivers who overestimate themselves, we seek to be above-average stock pickers by doing the things that most professional investors struggle with, like being courageous and patient. 
Via Talk Markets
Behind the Scenes of Amgen's Latest Options Trends
Via Benzinga
Why the dividend investor may take a look at NASDAQ:AMGN.
Exploring AMGEN INC (NASDAQ:AMGN)'s dividend characteristics. 
Via Chartmill
Amgen Dips Despite Beating Fourth-Quarter Sales Expectations
Amgen beat sales and earnings estimates late Tuesday, helped by nine products that hit record sales. 
Via Investor's Business Daily
Earnings Scheduled For February 6, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review
The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Are these frigid Dow stocks in for a longer winter?
These three Dow laggards have suffered double-digit percentage declines this winter, contributing to the Dow’s underperformance versus other major averages. 
Via MarketBeat
Topics Economy Stocks
Exposures Economy US Equities
2 Unstoppable Stocks to Buy and Hold for 2024 and Beyond
These great businesses are persisting and thriving through challenging economic times. 
Via The Motley Fool
Preview: Amgen's Earnings
Via Benzinga
Is Amgen Stock a Buy Now?
The biotech has an excellent track record, but that isn't enough to make its shares attractive. 
Via The Motley Fool
Amgen Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Investors' Focus Around Amgen's Obesity Drug Data Shadows Better Than Expected Q4 Earnings
Amgen's Q4 2023: 15% net profit growth, $8.2 billion total revenues beat expectations. Prolia leads with 12% sales jump. Analysts' reactions and price targets. 
Via Benzinga
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments... 
Via Benzinga
Topics Stocks
Exposures US Equities
META The Next Great Dividend Growth Stock – Growth Stock – Either Or Both?
A technical analysis of Meta Platforms Inc. (aka Facebook) and its recent initiation of a dividend. 
Via Talk Markets
Expert Outlook: Amgen Through The Eyes Of 11 Analysts
Via Benzinga
Is Amgen a Good Dividend Stock to Buy Right Now?
Its diverse product mix and strong fundamentals make a decent case. 
Via The Motley Fool
34% of the Dow Jones Industrial Average's Weighting Is Determined by Just 5 Stocks
Five well-known Dow Jones components account for more than a third -- over 13,100 points -- of its value. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in... 
Via Benzinga
Topics Economy
Exposures Interest Rates
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
3 Fantastic Dow Stocks to Buy in February 2024
The venerable index is more representative of today's economy and these three Dow stocks to buy are brightly shining component stars. 
Via InvestorPlace
Topics Economy Stocks
Exposures Economy US Equities
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs. 
Via InvestorPlace
Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record
Amgen is looking to rival Eli Lilly and Novo Nordisk in weight-loss drugs. 
Via Investor's Business Daily
Weight Loss Drug's New Entrant: Amgen To Compete With Novo Nordisk, Eli Lilly, As Investigational Weight Loss Drug Shows Encouraging Early Data
Amgen's AMG 133 data. Promising results in obesity drug trials, including significant weight loss and improved metabolic markers. 
Via Benzinga
IBM, Verizon, Merck stocks lead Dow to new highs
The Dow hits record highs with IBM, Verizon, Merck, and insurer Travelers leading the way; those strong stocks don't make much of a dent in S&P performance 
Via MarketBeat
Topics Stocks
Exposures US Equities
Amgen's Planning to Take a Bite Out of Cancer. Here's What It Means for the Stock.
Its new approach to treating cancer is more than just a nibble around the edges. 
Via The Motley Fool
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
53 54 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.